Methotrexate
Showing 51 - 75 of 2,805
Methotrexate on Sperm Quality in Inflammatory Bowel Disease
Recruiting
- Inflammatory Bowel Disease (IBD)
- Semen & Data Collection
-
Madison, WisconsinUniversity of Wisconsin Hospital & Clinics
Jul 7, 2022
Ectopic Pregnancy Trial in Multan (Methotrexate)
Completed
- Ectopic Pregnancy
- Methotrexate
-
Multān, Pu, PakistanNishtar Medical University Hospital
Jan 25, 2022
KRAS Gene Mutation, Metastatic Malignant Tumor in the Brain, Recurrent Non-Small Cell Lung Carcinoma Trial in Palo Alto
Active, not recruiting
- KRAS Gene Mutation
- +3 more
- Methotrexate
- +2 more
-
Palo Alto, CaliforniaStanford University School of Medicine
Feb 9, 2022
CNS Lymphoma Trial in China (Selinexor, Rituximab, Methotrexate)
Not yet recruiting
- Central Nervous System Lymphoma
- Selinexor
- +2 more
-
Hefei, Anhui, China
- +4 more
Jan 26, 2023
Bullous Pemphigoid Trial in Montpellier (clobetasol propionate + Methotrexate, clobetasol propionate alone)
Completed
- Bullous Pemphigoid
- clobetasol propionate + Methotrexate
- clobetasol propionate alone
-
Montpellier, FranceUniversity Hospital Of Montpellier
Jan 24, 2022
Rheumatoid Arthritis Trial (Natrunix with MTX (+folate), Natrunix with MTX (+folate))
Not yet recruiting
- Rheumatoid Arthritis
- Natrunix with MTX placebo (+folate)
- Natrunix placebo with MTX (+folate)
- (no location specified)
May 2, 2022
Rheumatoid Arthritis Trial in Saint-Étienne (Blood sample, CRQ)
Recruiting
- Rheumatoid Arthritis
- Blood sample
- CRQ
-
Saint-Étienne, FranceChu Saint Etienne
Feb 15, 2022
Warts Trial (topical methotrexate hydrogel 1% coupled with microneedling., Liquid nitrogen)
Not yet recruiting
- Warts
- topical methotrexate hydrogel 1% coupled with microneedling.
- Liquid nitrogen
- (no location specified)
Mar 18, 2022
Erythema Nodosum Leprosum Trial in Worldwide (Methotrexate, Placebo, Prednisolone)
Not yet recruiting
- Erythema Nodosum Leprosum
- Methotrexate
- +2 more
-
Dhaka, Bangladesh
- +6 more
Aug 23, 2022
Methotrexate and Azathioprine as Background Treatment for
Not yet recruiting
- Uveitis
-
Brest, FranceCHU de Brest
May 10, 2022
Rheumatoid Arthritis Trial in Chi?inau (AP1189, 60 mg, AP1189, 80 mg, AP1189, 100 mg)
Recruiting
- Rheumatoid Arthritis
- AP1189, 60 mg
- +3 more
-
Chișinău, Moldova, Republic ofTimofei Mosneaga Republican Clinical Hospital
Jan 5, 2023
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia, BCR-ABL1 Fusion Protein
Recruiting
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +7 more
- Blinatumomab
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Dec 31, 2022
Rheumatoid Arthritis Trial (MBS2320 5 mg, MBS2320 20 mg, MBS2320 40 mg)
Not yet recruiting
- Rheumatoid Arthritis
- MBS2320 5 mg
- +3 more
- (no location specified)
Jul 12, 2022
Uveitis Trial in Guangzhou (Adalimumab plus Methotrexate)
Recruiting
- Uveitis
- Adalimumab plus Methotrexate
-
Guangzhou, Guangdong, ChinaZhongshan Ophthalmic Center, Sun Yat-sen University
Dec 26, 2021
Arthritis, Rheumatoid Trial in France (Metformin treatment, Placebo, Methotrexate treatment)
Recruiting
- Arthritis, Rheumatoid
- Metformin treatment
- +2 more
-
Bordeaux, France
- +10 more
Apr 6, 2022
Primary CNS Lymphoma, PCNSL, Non Hodgkin Lymphoma Trial in Guandong, Guangzhou (Methotrexate, Ibrutinib, Temozolomide)
Recruiting
- Primary Central Nervous System Lymphoma
- +2 more
- Methotrexate
- +2 more
-
Guandong, Guangdong, China
- +2 more
Apr 6, 2022
Rheumatoid Arthritis Trial in Sweden (Methotrexate)
Recruiting
- Rheumatoid Arthritis
- Methotrexate
-
Eskilstuna, Sweden
- +10 more
Jun 28, 2022
Secondary CNS Lymphoma Trial in Beijing (Zanubrutinib, high-dose methotrexate (HD-MTX), rituximab)
Recruiting
- Secondary Central Nervous System Lymphoma
- Zanubrutinib, high-dose methotrexate (HD-MTX), rituximab
-
Beijing, Beijing, ChinaPeking University Cancer Hospital & Institute
May 25, 2022
Arthritis, Juvenile Trial in Worldwide (Golimumab, Methotrexate)
Active, not recruiting
- Arthritis, Juvenile
- Golimumab
- Methotrexate
-
San Diego, California
- +37 more
Jan 17, 2023
Rheumatoid Arthritis, JAK Inhibitor, Musculoskeletal Ultrasound Trial in Nagasaki (upadacitinib 15mg/day)
Recruiting
- Rheumatoid Arthritis
- +3 more
- upadacitinib 15mg/day
-
Nagasaki, JapanNagasaki University Hospital
Nov 24, 2021